carbamazepine has been researched along with Cardiovascular Diseases in 12 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to investigate risk factors for cardiovascular disease in patients with epilepsy using the new antiepileptic drug levetiracetam (LEV), compared with patients taking carbamazepine (CBZ) or lamotrigine (LTG)." | 7.76 | Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine. ( Gjerstad, L; Luef, G; Mørkrid, L; Rauchenzauner, M; Svalheim, S; Taubøll, E, 2010) |
| "The aim of the study was to investigate risk factors for cardiovascular disease in patients with epilepsy using the new antiepileptic drug levetiracetam (LEV), compared with patients taking carbamazepine (CBZ) or lamotrigine (LTG)." | 3.76 | Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine. ( Gjerstad, L; Luef, G; Mørkrid, L; Rauchenzauner, M; Svalheim, S; Taubøll, E, 2010) |
| "Although mania defines bipolar I disorder, depressive episodes and symptoms dominate the longitudinal course of, and disproportionately account for morbidity and mortality in, bipolar disorders." | 2.66 | Bipolar disorders. ( Berk, M; Brietzke, E; Goldstein, BI; Kessing, LV; López-Jaramillo, C; Majeed, A; Malhi, GS; Mansur, RB; McIntyre, RS; Nierenberg, AA; Rosenblat, JD; Vieta, E; Vinberg, M; Young, AH, 2020) |
| " When prescribing these drugs to patients of this age bracket, treatment should be based not only on the diagnosis and seizure type but also on the propensity of the drugs for adverse effects and their drug-drug interactions." | 2.48 | Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects. ( Dostic, M; Jankovic, SM, 2012) |
| "Clinically significant cardiovascular toxicity occurs rarely in patients with toxic carbamazepine concentrations." | 1.29 | Cardiovascular effects of carbamazepine toxicity. ( Apfelbaum, JD; Bossart, PJ; Caravati, EM; Kerns, WP; Larsen, G, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Larsson, D | 1 |
| Baftiu, A | 1 |
| Johannessen Landmark, C | 1 |
| von Euler, M | 1 |
| Kumlien, E | 1 |
| Åsberg, S | 1 |
| Zelano, J | 1 |
| McIntyre, RS | 1 |
| Berk, M | 1 |
| Brietzke, E | 1 |
| Goldstein, BI | 1 |
| López-Jaramillo, C | 1 |
| Kessing, LV | 1 |
| Malhi, GS | 1 |
| Nierenberg, AA | 1 |
| Rosenblat, JD | 1 |
| Majeed, A | 1 |
| Vieta, E | 1 |
| Vinberg, M | 1 |
| Young, AH | 1 |
| Mansur, RB | 1 |
| Harit, D | 1 |
| Aggarwal, A | 1 |
| Kalra, S | 1 |
| Chhillar, N | 1 |
| Pulido Fontes, L | 1 |
| Pulido Fontes, M | 1 |
| Quesada Jiménez, P | 1 |
| Muruzabal Pérez, J | 1 |
| Mendioroz Iriarte, M | 1 |
| Svalheim, S | 1 |
| Luef, G | 1 |
| Rauchenzauner, M | 1 |
| Mørkrid, L | 1 |
| Gjerstad, L | 2 |
| Taubøll, E | 2 |
| Jankovic, SM | 1 |
| Dostic, M | 1 |
| Kilbourne, AM | 1 |
| Post, EP | 1 |
| Bauer, MS | 1 |
| Zeber, JE | 1 |
| Copeland, LA | 1 |
| Good, CB | 1 |
| Pincus, HA | 1 |
| Badiou, S | 1 |
| Breton, H | 1 |
| Peyriere, H | 1 |
| Charasson, V | 1 |
| Crespel, A | 1 |
| Gelisse, P | 1 |
| Cristol, JP | 1 |
| Hillaire-Buys, D | 1 |
| Apfelbaum, JD | 1 |
| Caravati, EM | 1 |
| Kerns, WP | 1 |
| Bossart, PJ | 1 |
| Larsen, G | 1 |
| Quinn, MJ | 1 |
| Fitzgerald, DJ | 1 |
| Isojärvi, JI | 1 |
| Pakarinen, AJ | 1 |
| van Parys, J | 1 |
| Rättyä, J | 1 |
| Harbo, HF | 1 |
| Dale, PO | 1 |
| Fauser, BC | 1 |
| Koivunen, R | 1 |
| Knip, M | 1 |
| Tapanainen, JS | 1 |
| Muuronen, A | 1 |
| Kaste, M | 1 |
| Nikkilä, EA | 1 |
| Tolppanen, EM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Levetiracetam, Carbamazepine and Lamotrigine and Hormonal Side Effects in Adult Males and Females.[NCT00460070] | 240 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for carbamazepine and Cardiovascular Diseases
| Article | Year |
|---|---|
Bipolar disorders.
Topics: Adolescent; Adult; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; B | 2020 |
Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects.
Topics: Aged; Animals; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Choice Behavior; Drug Intera | 2012 |
Ticlopidine and clopidogrel.
Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angina, Unstable; Aspirin; Bo | 1999 |
1 trial available for carbamazepine and Cardiovascular Diseases
| Article | Year |
|---|---|
Comparison of carbamazepine and oxcarbazepine effects on aminothiol levels.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Cysteine; Dipeptides; Ep | 2008 |
8 other studies available for carbamazepine and Cardiovascular Diseases
| Article | Year |
|---|---|
Association Between Antiseizure Drug Monotherapy and Mortality for Patients With Poststroke Epilepsy.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Cohort Studies; Dr | 2022 |
Effect of Carbamazepine and Valproate Monotherapy on Cardiovascular Risks in Epileptic Children.
Topics: Anticonvulsants; Apolipoproteins A; Apolipoproteins B; Blood Chemical Analysis; Carbamazepine; Cardi | 2015 |
Comparative case-control study of homocysteine, vitamin B
Topics: Adult; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Case-Control Studies; Epilepsy; Fema | 2017 |
Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Comorbidity; Epilepsy; F | 2010 |
Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Cardiovascular Diseases; Drug Monitori | 2007 |
Cardiovascular effects of carbamazepine toxicity.
Topics: Adolescent; Adult; Aged; Carbamazepine; Cardiovascular Diseases; Child; Child, Preschool; Electrocar | 1995 |
Altered ovarian function and cardiovascular risk factors in valproate-treated women.
Topics: Adult; Analysis of Variance; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Case-Control S | 2001 |
Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study.
Topics: Aged; Anticonvulsants; Barbiturates; Carbamazepine; Cardiovascular Diseases; Cerebrovascular Disorde | 1985 |